PT  - JOURNAL ARTICLE
AU  - Karabay, Aknur
AU  - Kuzdeuov, Askat
AU  - Varol, Huseyin Atakan
TI  - COVID-19 Vaccination Strategies Considering Hesitancy Using Particle-Based Epidemic Simulation
AID  - 10.1101/2021.09.26.21264153
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.09.26.21264153
4099  - http://medrxiv.org/content/early/2021/09/28/2021.09.26.21264153.short
4100  - http://medrxiv.org/content/early/2021/09/28/2021.09.26.21264153.full
AB  - Vaccine hesitancy is one of the critical factors in achieving herd immunity and suppressing the COVID-19 epidemic. Many countries face this as an acute public health issue that diminishes the efficacy of their vaccination campaigns. Epidemic modeling and simulation can be used to predict the effects of different vaccination strategies. In this work, we present an open-source particle-based COVID-19 simulator with a vaccination module capable of taking into account the vaccine hesitancy of the population. To demonstrate the efficacy of the simulator, we conducted extensive simulations for the province of Lecco, Italy. The results indicate that the combination of both high vaccination rate and low hesitancy leads to faster epidemic suppression.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A https://github.com/IS2AI/Particle-Based-COVID19-Simulator/tree/Vaccine-Hesitancy-model